4.1 Review

Asthma and rhinitis: what is the relationship?

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ACI.0b013e328357cc32

关键词

airway inflammation; asthma; corticosteroids; FeNo; rhinitis

资金

  1. AstraZeneca
  2. GlaxoSmithKline
  3. Merck
  4. Novartis
  5. GSK
  6. Schering
  7. Altair
  8. Amgen
  9. Asmacure
  10. Boehringer-Ingelheim
  11. Genentech
  12. Pharmaxis
  13. Wyeth
  14. CIHR

向作者/读者索取更多资源

Purpose of review Asthma and rhinitis are commonly associated and they influence their respective control. New observations have contributed to better understand how to assess those conditions and how they influence each other. Recent findings Recent studies found that not only the intensity, but also the duration of rhinitis could be correlated with the development of asthma and possibly its remission. The measure of exhaled nitric oxide (FeNO) has been used to show the presence of lower airway inflammation in rhinitic patients, with or without asthma. Furthermore, it has been shown that allergic rhinitis could affect asthma control in children as in adults, and consequently suggested that allergic rhinitis and asthma should be concomitantly approached in regard to their diagnosis and treatment. Additional observations showed improvements in various asthma outcomes with the treatment of rhinitis. Summary These new data confirm the strong link between asthma and rhinitis, the importance of their interactions, and the need to identify and treat rhinitis adequately in asthmatic patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据